<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03632902</url>
  </required_header>
  <id_info>
    <org_study_id>HCB/2018/0691</org_study_id>
    <nct_id>NCT03632902</nct_id>
  </id_info>
  <brief_title>Airway Management With Supraglottic Devices in Unruptured Intracranial Aneurysms</brief_title>
  <official_title>Airway Management With Supraglottic Devices in Unruptured Intracranial Aneurysm Endovascular Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion Clinic per a la Recerca Biomédica</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundacion Clinic per a la Recerca Biomédica</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endovascular techniques for the treatment of intracranial aneurysms are growing.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Retrospective analysis of the investigators experience in the last 8 years with the airway
      management in endovascular therapy for unruptured aneurysms. A total of 206 participants will
      be included from 2010 to 2018. Airway management (anticipated difficult airway, need for LM
      repositioning, orotracheal intubation because of failed laryngeal mask insertion, airway
      complication), intraoperative monitoring, aneurism size and location, intraoperative and
      perioperative complications will be registered.

      Statistics will be compared between groups with t test or x test, as appropriate.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 26, 2018</start_date>
  <completion_date type="Actual">November 20, 2019</completion_date>
  <primary_completion_date type="Actual">October 20, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Security in the use of supraglottic devices in the unruptured intracranial aneurysms.</measure>
    <time_frame>ten years</time_frame>
    <description>security; the incidence of adverse events during the procedure and post-procedure will be recorded, also morbidity and mortality in patients managed with supraglottic devices during unruptured aneurysm embolization</description>
  </primary_outcome>
  <enrollment type="Actual">205</enrollment>
  <condition>Airway Management</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>supraglottic device</intervention_name>
    <description>airway management will be collected</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who underwent endovascular treatment for unruptured aneurysm in the past 8 years
        in our institution
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients that underwent endovascular treatment for unruptured aneurysm

        Exclusion Criteria:

          -  ruptured aneurysm
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>PAOLA A HURTADO RESTREPO, md</last_name>
    <role>Principal Investigator</role>
    <affiliation>anesthesiologist in Hospital Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Clinic</name>
      <address>
        <city>Barcelona</city>
        <state>Cataluña</state>
        <zip>08019</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>June 26, 2018</study_first_submitted>
  <study_first_submitted_qc>August 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 16, 2018</study_first_posted>
  <last_update_submitted>May 27, 2020</last_update_submitted>
  <last_update_submitted_qc>May 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundacion Clinic per a la Recerca Biomédica</investigator_affiliation>
    <investigator_full_name>Ricard Valero</investigator_full_name>
    <investigator_title>head of neuroanesthesia section</investigator_title>
  </responsible_party>
  <keyword>supraglottic devices</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

